194 related articles for article (PubMed ID: 8380275)
1. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization.
Bellamy CO; McDonald C; Salter DM; Chetty U; Anderson TJ
Hum Pathol; 1993 Jan; 24(1):16-23. PubMed ID: 8380275
[TBL] [Abstract][Full Text] [Related]
2. Tenascin patterns of expression in duct carcinoma in situ of the breast.
Iskaros BE; Sison CP; Hajdu SI
Ann Clin Lab Sci; 2000 Jul; 30(3):266-71. PubMed ID: 10945566
[TBL] [Abstract][Full Text] [Related]
3. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
4. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
5. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone.
Schwartz GF; Finkel GC; Garcia JC; Patchefsky AS
Cancer; 1992 Nov; 70(10):2468-74. PubMed ID: 1330281
[TBL] [Abstract][Full Text] [Related]
6. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
7. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.
Lagios MD; Margolin FR; Westdahl PR; Rose MR
Cancer; 1989 Feb; 63(4):618-24. PubMed ID: 2536582
[TBL] [Abstract][Full Text] [Related]
8. Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.
Vicini FA; Goldstein NS; Kestin LL
Ann Oncol; 1999 Aug; 10(8):883-90. PubMed ID: 10509147
[TBL] [Abstract][Full Text] [Related]
9. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.
Page DL; Dupont WD; Rogers LW; Jensen RA; Schuyler PA
Cancer; 1995 Oct; 76(7):1197-200. PubMed ID: 8630897
[TBL] [Abstract][Full Text] [Related]
10. Residual tumor after primary excision of ductal carcinoma in situ (DCIS), on re-excision specimens.
Nistor-Ciurba CC
Rom J Morphol Embryol; 2012; 53(3 Suppl):821-5. PubMed ID: 23188447
[TBL] [Abstract][Full Text] [Related]
11. Recurrence after lumpectomy for comedo-type intraductal carcinoma of the breast.
Baird RM; Worth A; Hislop G
Am J Surg; 1990 May; 159(5):479-81. PubMed ID: 2159245
[TBL] [Abstract][Full Text] [Related]
12. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age.
Goldstein NS; Vicini FA; Kestin LL; Thomas M
Cancer; 2000 Jun; 88(11):2553-60. PubMed ID: 10861433
[TBL] [Abstract][Full Text] [Related]
13. Ductal carcinoma in situ (DCIS): a revised concept.
Gump FE; Jicha DL; Ozello L
Surgery; 1987 Nov; 102(5):790-5. PubMed ID: 2823405
[TBL] [Abstract][Full Text] [Related]
14. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
15. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
16. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
17. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy.
Kerlikowske K; Molinaro A; Cha I; Ljung BM; Ernster VL; Stewart K; Chew K; Moore DH; Waldman F
J Natl Cancer Inst; 2003 Nov; 95(22):1692-702. PubMed ID: 14625260
[TBL] [Abstract][Full Text] [Related]
20. Treatment of ductal carcinoma in situ of the breast.
Moore MM
Semin Surg Oncol; 1991; 7(5):267-70. PubMed ID: 1663649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
